News | July 14, 2010

MRI-Compatible Pacing System Receives CE Mark

July 14, 2010 – Medtronic Inc. recently announced it has received CE (Conformité Européenne) Mark for the Ensura MRI SureScan pacing system. Ensura MRI is the company’s new option in a portfolio of devices from Medtronic that have been designed, tested and approved for use with MRI machines. Patients with this new SureScan pacing system will have access to full body scans, without positioning restrictions in the MRI scanner. The Ensura MRI SureScan pacing system currently is not approved for sale in the United States.

Approximately two million Europeans have implanted pacemakers; however, these patients are strongly discouraged from receiving MRI scans, a widely practiced diagnostic method for many common diseases and conditions, such as cancer, neurological disorders and orthopedic injuries. It is possible current pacing systems could interact with MRI machines, potentially affecting the device or patient safety. According to estimates, 50 to 75 percent of patients worldwide with implanted cardiac devices are expected to need an MRI scan during the lifetime of their devices. [1] MRI is the standard of care in soft tissue imaging, providing information not seen with X-ray, ultrasound, or CT scan, and critical for early detection, diagnosis and treatment.

References:

1. Kalin R., Stanton M.S. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing and Clinical Electrophysiology. April 2005; 28(4): 326-328.

Related Content

Circle Cardiovascular Imaging and Galgo Medical Enter Distribution and Joint Development Agreement
News | Magnetic Resonance Imaging (MRI) | February 14, 2019
Circle Cardiovascular Imaging and Galgo Medical recently announced an agreement for distribution and joint development...
FDA Clears Magnetom Lumina 3T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | January 30, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic resonance imaging (...
HeartVista Announces One Click Autonomous MRI Solution
News | Magnetic Resonance Imaging (MRI) | November 25, 2018
HeartVista announced its artificial intelligence (AI)-driven, One-Click Autonomous MRI acquisition software for cardiac...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
Stress Cardiac MRI Shows High Prognostic Value for Suspected Ischemia Patients
News | Magnetic Resonance Imaging (MRI) | September 17, 2018
Raymond Kwong, M.D., MPH, from the Harvard Medical School recently presented his findings on a study of how single-...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

Feature | Magnetic Resonance Imaging (MRI) | February 28, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Overlay Init